W 15 (Pioglitazone Hydrochloride 15 mg (base))
Pill with imprint W 15 is White, Round and has been identified as Pioglitazone Hydrochloride 15 mg (base). It is supplied by Watson Laboratories, Inc..
Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for W 15
- W 15
- 15 mg (base)
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- carboxymethylcellulose calcium
hydroxypropyl cellulose (type l)
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|68084-0878||Amerisource Health Services|
More about pioglitazone
- Pioglitazone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: thiazolidinediones
Other brands: Actos
- Pioglitazone Hydrochloride (AHFS Monograph)
- Pioglitazone Tablets (FDA)
- Pioglitazone (Wolters Kluwer)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.